⌘K

Home/Filings/4/0001562180-22-001872

4//SEC Filing

Bures Thomas 4

Accession 0001562180-22-001872

CIK 0001583648other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:46 PM ET

Size

8.9 KB

Accession

0001562180-22-001872

Insider Transaction Report

Form 4

Period: 2022-02-22

PIERIS PHARMACEUTICALS, INC.PIRS

Vice President, Finance

Transactions

Award
Stock Options (Right to buy)
2022-02-22+215,819→ 215,819 total
Exercise: $3.03Exp: 2032-02-22→ Common Stock (215,819 underlying)

Footnotes (1)

[F1]The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.

Documents

2 files

Issuer

PIERIS PHARMACEUTICALS, INC.

CIK 0001583648

Entity typeother

Related Parties

1

filerCIK 0001787029

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 4:46 PM ET
Size: 8.9 KB

View on SEC.gov